SCN9A and hereditary sensory and autonomic neuropathy: Importantly, the genetic ablation of SCN9A in mice and in a human CIP patient, the absence of functional Nav1.7 leads to increases in endogenous opioid-dependent analgesia and diminished pain-induced peripheral nociceptive drive (Minett et al., 2015).